Top Buy
| Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Vericel Corp. | 1 | 0 | 0 | 0 | €43.20 | - | - |
| Vanda Pharmaceuticals | 4 | 0 | 0 | 0 | €4.60 | €5.00 | 8.696% |
| Amgen Inc. | 25 | 0 | 0 | 0 | €279.30 | €296.16 | 6.035% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 0 | 0 | €39.20 | €50.00 | 27.551% |
| Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | €23.20 | €21.66 | -6.642% |
| Geron Corp. | 12 | 0 | 0 | 0 | €3.09 | €4.63 | 49.509% |
| Xencor Inc. | 10 | 1 | 0 | 0 | €21.20 | €32.58 | 53.674% |
| Charles River Labs Intl | 10 | 0 | 0 | 0 | €195.70 | €248.57 | 27.016% |
| Exelixis Inc. | 18 | 0 | 0 | 0 | €19.00 | €26.01 | 36.912% |
| Anika Therapeutics | 5 | 0 | 0 | 0 | €22.80 | €28.29 | 24.082% |
| AnaptysBio Inc | 8 | 1 | 0 | 0 | €21.40 | €45.21 | 111.262% |
| Sangamo Therapeutics Inc. | 12 | 12 | 0 | 0 | €0.51 | €3.63 | 610.772% |
| SCYNEXIS Inc. | 5 | 0 | 0 | 0 | €2.05 | €8.35 | 308.250% |
| Lexicon Pharmaceuticals Inc. | 2 | 0 | 0 | 0 | €1.53 | €5.34 | 249.443% |
| Immunogen Inc. | 4 | 0 | 0 | 0 | €28.97 | - | - |
| Rigel Pharmaceutical Inc. | 10 | 0 | 0 | 0 | €0.86 | €13.77 | 1508.056% |
| Actinium Pharmaceuticals Inc. | 3 | 0 | 0 | 0 | €7.28 | €8.50 | 16.758% |
| Amneal Pharmaceuticals Inc | 1 | 1 | 0 | 0 | €6.40 | €10.00 | 56.250% |
| Catalent Inc. | 1 | 0 | 0 | 0 | €49.61 | €55.00 | 10.865% |
| AbbVie Inc. | 22 | 0 | 0 | 0 | €143.68 | €175.11 | 21.876% |
| Biocryst Pharmaceuticals | 9 | 0 | 0 | 0 | €5.68 | €11.05 | 94.561% |
| Repligen Corp. | 13 | 0 | 0 | 0 | €140.00 | €184.76 | 31.971% |
| TG Therapeutics Inc. | 22 | 4 | 0 | 0 | €15.15 | €28.06 | 85.220% |
| Apellis Pharmaceuticals | 3 | 0 | 0 | 0 | €38.06 | €70.00 | 83.920% |
| Esperion Therapeutis.Inc. | 15 | 0 | 0 | 0 | €2.03 | €8.55 | 320.339% |